BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26260813)

  • 21. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
    Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
    Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
    Babashah S; Soleimani M
    Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncomirs: from tumor biology to molecularly targeted anticancer strategies.
    Mocellin S; Pasquali S; Pilati P
    Mini Rev Med Chem; 2009 Jan; 9(1):70-80. PubMed ID: 19149661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory mechanisms and clinical perspectives of miR-34a in cancer.
    Li L
    J Cancer Res Ther; 2014; 10(4):805-10. PubMed ID: 25579512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
    Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
    Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
    Blenkiron C; Miska EA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis.
    Maroof H; Salajegheh A; Smith RA; Lam AK
    Exp Mol Pathol; 2014 Oct; 97(2):298-304. PubMed ID: 25102298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
    Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
    J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of miRNAs in cancer: from pathogenesis to therapeutic implications.
    Seven M; Karatas OF; Duz MB; Ozen M
    Future Oncol; 2014 May; 10(6):1027-48. PubMed ID: 24941988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in tumor angiogenesis.
    Wang W; Zhang E; Lin C
    Life Sci; 2015 Sep; 136():28-35. PubMed ID: 26144623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncomirs - microRNAs with a role in cancer.
    Esquela-Kerscher A; Slack FJ
    Nat Rev Cancer; 2006 Apr; 6(4):259-69. PubMed ID: 16557279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNAs: Master regulators as potential therapeutics in cancer.
    Garofalo M; Croce CM
    Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs as tumor suppressors.
    Hammond SM
    Nat Genet; 2007 May; 39(5):582-3. PubMed ID: 17460676
    [No Abstract]   [Full Text] [Related]  

  • 37. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
    Renjie W; Haiqian L
    Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; García-Serna AM; Gómez-Espuch J; Moraleda JM; Minguela A; García-Alonso AM; Parrado A
    PLoS One; 2015; 10(4):e0124936. PubMed ID: 25909590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.